SKI Market

Indian Indices

Sensex

84,180.96 -780.18
( -0.92%)

Global Indices

Nasdaq

49,008.56 -474.53
(-0.96%)

Dow Jones

6,942.66 -23.16
(-0.33%)

Hang Seng

51,148.76 -813.22
(-1.57%)

Nikkei 225

10,039.39 -83.34
(-0.82%)

Forex

USD-INR

90.15 -0.06
(-0.07%)

EUR-INR

105.56 0.04
(0.04%)

GBP-INR

121.94 0.39
(0.32%)

JPY-INR

0.58 0.00
(0.08%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bafna Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532989

INE878I01022

38.5638498

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BAFNAPH

32.86

347.51

EPS(TTM)

Face Value()

Div & Yield %

4.47

Back

PTC Industries consolidated net profit rises 4.79% in the September 2025 quarter

Nov 15,2025

Net profit of PTC Industries rose 4.79% to Rs 18.14 crore in the quarter ended September 2025 as against Rs 17.31 crore during the previous quarter ended September 2024. Sales rose 72.21% to Rs 124.63 crore in the quarter ended September 2025 as against Rs 72.37 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	124.63	72.37	72
OPM %	20.65	29.35	-
PBDT	32.07	26.24	22
PBT	22.97	22.03	4
NP	18.14	17.31	5

84,180.96 -780.18 ( -0.92%)

49,008.56 -474.53 (-0.96%)

6,942.66 -23.16 (-0.33%)

51,148.76 -813.22 (-1.57%)

10,039.39 -83.34 (-0.82%)

90.15 -0.06 (-0.07%)

105.56 0.04 (0.04%)

121.94 0.39 (0.32%)

0.58 0.00 (0.08%)